scholarly article | Q13442814 |
P356 | DOI | 10.1006/METH.1999.0745 |
P698 | PubMed publication ID | 10196102 |
P2093 | author name string | Salvesen GS | |
Stennicke HR | |||
P433 | issue | 4 | |
P304 | page(s) | 313-319 | |
P577 | publication date | 1999-04-01 | |
P1433 | published in | Methods | Q6823859 |
P1476 | title | Caspases: preparation and characterization | |
P478 | volume | 17 |
Q34448294 | A biocompatible "split luciferin" reaction and its application for non-invasive bioluminescent imaging of protease activity in living animals |
Q37331739 | A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice. |
Q37043619 | A coupled protein and probe engineering approach for selective inhibition and activity-based probe labeling of the caspases |
Q27670443 | A designed redox-controlled caspase |
Q28609101 | A unified model for apical caspase activation |
Q42423646 | Activation and specificity of human caspase-10. |
Q33321770 | Activation mechanism and substrate specificity of the Drosophila initiator caspase DRONC. |
Q34328223 | Activation of caspases-8 and -10 by FLIP(L). |
Q40330849 | Activity-based probes that target diverse cysteine protease families |
Q27679175 | Allosteric modulation of caspase 3 through mutagenesis |
Q40191055 | Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor |
Q27651006 | An Allosteric Circuit in Caspase-1 |
Q35058831 | An Uncleavable Procaspase-3 Mutant Has a Lower Catalytic Efficiency but an Active Site Similar to That of Mature Caspase-3 |
Q36282498 | An inhibitory mono-ubiquitylation of the Drosophila initiator caspase Dronc functions in both apoptotic and non-apoptotic pathways |
Q36294082 | Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins |
Q24670606 | Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma |
Q24669658 | Caspase 3 attenuates XIAP (X-linked inhibitor of apoptosis protein)-mediated inhibition of caspase 9 |
Q40569376 | Caspase activation inhibits proteasome function during apoptosis |
Q45985569 | Caspase assays: identifying caspase activity and substrates in vitro and in vivo. |
Q39764895 | Caspase cleavage of Ets-1 p51 generates fragments with transcriptional dominant-negative function |
Q88634204 | Caspase selective reagents for diagnosing apoptotic mechanisms |
Q38421517 | Caspase-1 promiscuity is counterbalanced by rapid inactivation of processed enzyme |
Q39680918 | Caspase-8 cleaves histone deacetylase 7 and abolishes its transcription repressor function |
Q52676492 | Caspase-9 CARD : core domain interactions require a properly formed active site. |
Q42169749 | Caspases |
Q28579902 | Characterization of a novel isoform of caspase-9 that inhibits apoptosis |
Q30165187 | Characterization of the apoptosis suppressor protein P49 from the Spodoptera littoralis nucleopolyhedrovirus. |
Q80151856 | Cleavage and degradation of Claspin during apoptosis by caspases and the proteasome |
Q36091342 | Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes |
Q27641840 | Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway |
Q27625472 | Crystal structure of the apoptotic suppressor CrmA in its cleaved form |
Q92229529 | Cytosolic Gram-negative bacteria prevent apoptosis by inhibition of effector caspases through lipopolysaccharide |
Q24673246 | Death receptor-induced apoptosis reveals a novel interplay between the chromosomal passenger complex and CENP-C during interphase |
Q40650481 | Design, Construction, and In Vitro Analyses of Multivalent Antibodies |
Q43002846 | Effect of caspase cleavage-site phosphorylation on proteolysis |
Q34977345 | Energy-Generating Enzymes of Burkholderia cepacia and Their Interactions with Macrophages |
Q33875874 | Evidence for a function of death-receptor-related, death-domain-containing proteins in anoikis |
Q92826615 | Exploring the prime site in caspases as a novel chemical strategy for understanding the mechanisms of cell death: a proof of concept study on necroptosis in cancer cells |
Q42169768 | Expression, purification, and characterization of caspases |
Q39883573 | Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene |
Q34032220 | Flow cytometry of apoptotic cell death |
Q36288119 | Highly sensitive and adaptable fluorescence-quenched pair discloses the substrate specificity profiles in diverse protease families |
Q46013323 | Human caspase-7 activity and regulation by its N-terminal peptide. |
Q40381709 | Identification and characterization of a novel mammalian caspase with proapoptotic activity |
Q33752885 | Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models |
Q36001454 | Identification of Protease Specificity by Combining Proteome-Derived Peptide Libraries and Quantitative Proteomics |
Q35202811 | In vitro cytotoxicity of Artemisia vulgaris L. essential oil is mediated by a mitochondria-dependent apoptosis in HL-60 leukemic cell line |
Q33854989 | Inflammatory stimuli regulate caspase substrate profiles |
Q44593876 | Inhibition of bleomycin-induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxol |
Q36529717 | Inhibition of caspase-9 by stabilized peptides targeting the dimerization interface |
Q28343620 | Inhibition of distant caspase homologues by natural caspase inhibitors |
Q43295977 | Inhibition of human initiator caspase 8 and effector caspase 3 by cross-class inhibitory bovSERPINA3-1 and A3-3. |
Q24532133 | Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8 |
Q42156615 | Ionic interactions near the loop L4 are important for maintaining the active-site environment and the dimer stability of (pro)caspase 3. |
Q33260826 | Isolation of intracellular proteinase inhibitors derived from designed ankyrin repeat proteins by genetic screening |
Q39582636 | MAGUKs, scaffolding proteins at cell junctions, are substrates of different proteases during apoptosis |
Q24290531 | ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas |
Q34151837 | Mechanism and specificity of the human paracaspase MALT1. |
Q35107497 | Mechanism of a genetically encoded dark-to-bright reporter for caspase activity |
Q39527536 | Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1. |
Q50918511 | Modulation of procaspase-7 self-activation by PEST amino acid residues of the N-terminal prodomain and intersubunit linker. |
Q41588503 | Molecular determinants involved in activation of caspase 7 |
Q35032909 | Mutations in the Procaspase-3 Dimer Interface Affect the Activity of the Zymogen |
Q35976375 | NMR-based techniques in the hit identification and optimisation processes |
Q50659185 | Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. |
Q40041395 | Polypeptide modulators of caspase recruitment domain (CARD)-CARD-mediated protein-protein interactions. |
Q93042068 | Potent and selective caspase-2 inhibitor prevents MDM-2 cleavage in reversine-treated colon cancer cells |
Q33950514 | Prediction of protease substrates using sequence and structure features |
Q37013419 | Protease activation of split green fluorescent protein |
Q42490786 | Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells |
Q37206086 | Quantitative studies of caspase-3 catalyzed αII-spectrin breakdown |
Q35058834 | Role of loop bundle hydrogen bonds in the maturation and activity of (Pro)caspase-3. |
Q38921103 | S-nitrosylation of XIAP at Cys 213 of BIR2 domain impairs XIAP's anti-caspase 3 activity and anti-apoptotic function |
Q37140171 | S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease |
Q24550879 | SATB1 cleavage by caspase 6 disrupts PDZ domain-mediated dimerization, causing detachment from chromatin early in T-cell apoptosis |
Q31821369 | Selective cleavage of BLM, the bloom syndrome protein, during apoptotic cell death |
Q36806640 | SfDronc, an initiator caspase involved in apoptosis in the fall armyworm Spodoptera frugiperda |
Q61450377 | Short Peptides with Uncleavable Peptide Bond Mimetics as Photoactivatable Caspase-3 Inhibitors |
Q80820912 | Small molecules not direct activators of caspases |
Q64168413 | Specificity of aza-peptide electrophile activity-based probes of caspases |
Q27685300 | Structural asymmetry of procaspase-7 bound to a specific inhibitor |
Q24290945 | Structural basis for the inhibition of caspase-3 by XIAP |
Q36742286 | Substrate and inhibitor-induced dimerization and cooperativity in caspase-1 but not caspase-3. |
Q41933022 | Synthesis of a HyCoSuL peptide substrate library to dissect protease substrate specificity |
Q37123892 | Targeting the XIAP/caspase-7 complex selectively kills caspase-3-deficient malignancies. |
Q43136832 | The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing |
Q42720175 | The effect of recombinant caspase 3 on myofibrillar proteins in porcine skeletal muscle |
Q24292195 | The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis |
Q41824992 | The structure of procaspase 6 is similar to that of active mature caspase 6. |
Q27666723 | Thermodynamic, enzymatic and structural effects of removing a salt bridge at the base of loop 4 in (pro)caspase-3. |
Q34038412 | Unnatural amino acids increase sensitivity and provide for the design of highly selective caspase substrates |
Q33648434 | Vaccinia virus protein F1L is a caspase-9 inhibitor |
Q40470946 | XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. |
Q36399260 | p38-MAPK signals survival by phosphorylation of caspase-8 and caspase-3 in human neutrophils |
Q53554762 | pC6-2/caspase-6 system to purify glutathione-S-transferase-free recombinant fusion proteins expressed in Escherichia coli. |
Search more.